6 March DRC Director's Update - March 2023 March 6, 2023 By The Fraternal Order of Eagles Diabetes Research Center DRC, Iowa, Diabetes, Diabetes Research Center 0 The treatments available for persons with cystic fibrosis and for persons with diabetes have both been advancing rapidly over the past half-decade. It is no surprise therefore that care for persons with both conditions, termed cystic fibrosis-related diabetes (CFRD), is advancing as well. An updated set of treatment guidelines for CFRD have been issued by the International Society for Pediatric and Adolescent Diabetes. The guidelines have been indexed in Pubmed and can be found here (https://doi.org/10.1111/pedi.13453). The lead author of the guidelines is Dr. Katie Larson Ode, who is one of the FOEDRC faculty. She is from the Division of Endocrinology and Diabetes of the Stead Family Department of Pediatrics. Her co-authors include CFRD experts from Minnesota, Colorado, Indiana, Philadelphia, Australia, Canada, Italy, and Germany. We are fortunate to have Dr. Larson Ode’s expertise and leadership in this field. Dr. Larson Ode international reputation stems from clinical studies she directed relating to diabetes in persons with cystic fibrosis. She was chosen by the Cystic Fibrosis Foundation to mentor a cadre of physicians across the country in the endocrine care of persons with cystic fibrosis and related clinical research. She has published multiple manuscripts in this area as well and is regularly invited to talk across the country and even internationally on this subject matter. Related Articles DRC Director's Report - March 2019 Brian T. O’Neill, MD, PhD, assistant professor in the Division of Endocrinology in the Department of Internal Medicine and member of the FOEDRC recently published in the journal Diabetes the discovery that FoxO proteins, which are transcription factors that regulate DNA, are the critical regulators of diabetes-related muscle atrophy. DRC Director's Report - May 2023 The Fraternal Order of Eagles Diabetes Research Center held its Annual Diabetes Research Day on Monday, April 17th. With a strong emphasis on collaboration and sharing of knowledge, this event brought together about 65 researchers, clinicians, and students to advance the understanding of diabetes and improve patient outcomes. Diabetes Research Day featured a lineup of activities including short talks, a keynote address, T32 presentations and a poster session DRC Director's Report - January 2023 The Fraternal Order of Eagles Diabetes Research Center held its 8th annual retreat on December 3, 2022, at the Terry Trueblood Recreation Center. DRC faculty and senior trainees came together for a day of research and celebration of the Center’s continued success. The day began with opening remarks by Co-Directors’ Kamal Rahmouni, PhD and Andrew Norris, MD, PhD followed by updates from the Metabolic Phenotyping Core and the Metabolomics Core Facility. We also heard from two new DRC faculty members, Bing Li, PhD, and Marcelo Correia, MD. This year we listened to presentations reporting annual progress from last year’s Pilot and Feasibility Grant Recipients, Katie Larson Ode, MD, Jon Resch, PhD, Ling Yang, PhD and Erin Talbert, PhD. DRC Director's Update - June 2019 In healthy adults, blood pressure (BP) decreases during sleep at night to lower levels than during the daytime. This phenomenon is referred to as nocturnal BP “dipping” and normally dips 10-20% compared with daytime. Blunted nocturnal BP dipping has been independently associated with increased cardiovascular disease (CVD) risk. The prevalence of blunted nocturnal BP dipping is higher in persons with obesity and diabetes, which are traditional risk factors for CVD. DRC Director's Update - August 2019 FOE Diabetes Research Center faculty recognize the importance of continuing the tradition of research excellence as we fight for the bridge to the cure. Because of this, part of our mission must be the preparation of the next generation of diabetes researchers. In addition to our commitment to training Ph.D. students and Postdoctoral scholars, the FOEDRC is a leader at the University of Iowa in providing research experience to our undergraduate students. DRC Director's Update - September 2019 It has long been known that increased abdominal fat, is a major risk factor for developing diabetes. A new study done by Yangbo Sun, MD, PhD, and colleagues, under supervision of Wei Bao, MD, PhD, assistant professor in the Department of Epidemiology and a member of the FOEDRC, has identified a concerning new and underrecognized complication of increased belly fat, namely a high-risk for premature death particularly in post-menopausal women, who might not be obese or overweight. Showing 0 Comment Comments are closed.